Daniel Lindholm
Uppsala University Hospital(SE)
Publications by Year
Research Areas
Diabetes Treatment and Management, Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Acute Myocardial Infarction Research, Antiplatelet Therapy and Cardiovascular Diseases
Most-Cited Works
- → Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction(2022)2,473 cited
- → Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction(2019)341 cited
- → Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial(2021)312 cited
- → Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER(2022)270 cited
- → Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial(2014)203 cited
- → Improved Patient Survival Using a Modified Resuscitation Protocol for Out-of-Hospital Cardiac Arrest(2009)192 cited
- → Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain.(1994)184 cited
- → Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF(2020)172 cited
- → Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF(2022)158 cited
- → Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction(2022)158 cited